Yingyu Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yingyu Wang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Bing Wang
Institute of Microcirculation, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China
4 shared publications - Bingwei Li
Institute of Microcirculation, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China
4 shared publications - Mingming Liu
Institute of Microcirculation, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China
4 shared publications - Weiqi Liu
Institute of Microcirculation, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China
3 shared publications - Xiang Xu
Institute of Microcirculation, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China
3 shared publications - Yuan Li
Institute of Microcirculation, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China
3 shared publications
Latest Publications
- Open Access
Microcirculation Mirror: A zero-install browser workstation for hand microvascular anatomy and nailfold capillaroscopy
Background: Hand microvasculature is conventionally presented through diagrams, cadaveric atlases and specialized optical instruments, while conventional clinical radiography cannot resolve individual capillary loops (5-15 µm lumen) in vivo, which dominate cutaneous oxygen exchange. Methods: We present Microcirculation Mirror , a zero-install browser workstation that registers layered hand anatomy to a live 21-landmark pose and couples it to a nailfold video capillaroscopy (NVC) simulator, a lumped microcirculatory model and an imaging-physics module. The single-file application runs offline on a laptop or, over local HTTPS, on a phone as an installable app. Results: Its 3D atlas contains 136 named structures per hand in six systems from open Z- Anatomy/BodyParts3D meshes, plus a literature-parameterized capillary layer. The NVC module renders a 200×, 1.2-mm field with six deterministic patterns and quantified density, giant capillaries, avascular width fraction, hemorrhages, tortuosity and ramification. A lumped model reports nine estimates (SIM); a physics module shows that a 10-µm capillary occupies 0.07 of a 150-µm detector pixel; with iodinated contrast it retains ≈0.016% effective contrast, about 60× below a 1% detection threshold; unenhanced blood is ≈270× lower. The 2D stage renders in 2.9 ms per frame; system merging reduces atlas draw calls from 136 to 6. Conclusions: The camera-overlay layers are templates, the atlas macro-anatomy is open mesh data, and the capillary layer is sampled. No patient data are used. The instrument is a product prototype, not a medical device, and provides a reproducible framework for making multi-scale microvascular reasoning visible.
Open AccessMicrocirculation Mirror: A zero-install browser workstation for hand microvascular anatomy and nailfold capillaroscopy
Background: Hand microvasculature is conventionally presented through diagrams, cadaveric atlases and specialized optical instruments, while conventional clinical radiography cannot resolve individual capillary loops (5-15 µm lumen) in vivo, which dominate cutaneous oxygen exchange. Methods: We present Microcirculation Mirror , a zero-install browser workstation that registers layered hand anatomy to a live 21-landmark pose and couples it to a nailfold video capillaroscopy (NVC) simulator, a lumped microcirculatory model and an imaging-physics module. The single-file application runs offline on a laptop or, over local HTTPS, on a phone as an installable app. Results: Its 3D atlas contains 136 named structures per hand in six systems from open Z- Anatomy/BodyParts3D meshes, plus a literature-parameterized capillary layer. The NVC module renders a 200×, 1.2-mm field with six deterministic patterns and quantified density, giant capillaries, avascular width fraction, hemorrhages, tortuosity and ramification. A lumped model reports nine estimates (SIM); a physics module shows that a 10-µm capillary occupies 0.07 of a 150-µm detector pixel; with iodinated contrast it retains ≈0.016% effective contrast, about 60× below a 1% detection threshold; unenhanced blood is ≈270× lower. The 2D stage renders in 2.9 ms per frame; system merging reduces atlas draw calls from 136 to 6. Conclusions: The camera-overlay layers are templates, the atlas macro-anatomy is open mesh data, and the capillary layer is sampled. No patient data are used. The instrument is a product prototype, not a medical device, and provides a reproducible framework for making multi-scale microvascular reasoning visible.
- Open Access
- 20 March 2026
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 30 (6) , e71098
Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells
The integrity of the pancreatic islet microvasculature is critical for endocrine function, yet it is progressively compromised by glucotoxicity in diabetes. While matrix metalloproteinases are implicated, the role of stromelysin‐1 as a potential upstream driver of endothelial dysfunction remains poorly defined. The aim of our study was to elucidate the role of stromelysin‐1 in mediating glucotoxic injury to islet microvascular endothelial cells (IMECs). To this end, we employed a CRISPR/Cas9‐mediated knockout of stromelysin‐1 in IMECs. Cellular functions, including proliferation, migration, and angiogenesis, were assessed using IncuCyte ZOOM live‐cell imaging, while endothelial barrier integrity was quantified via a 40 kDa dextran flux assay. Additionally, the secretome was profiled using a cytokine antibody array. We found that genetic ablation of stromelysin‐1 conferred protection against glucotoxicity. Stromelysin‐1 KO IMECs exhibited significantly enhanced proliferation, migration, and angiogenic capacity compared to wild‐type controls. Furthermore, stromelysin‐1 deficiency restored endothelial monolayer integrity by attenuating high‐glucose‐induced hyperpermeability. These functional improvements were linked to a remodelling of the secretome, characterised by decreased secretion of the pro‐degradative MMP‐2 and increased secretion of the anti‐inflammatory cytokine IL‐10 and the endogenous inhibitor TIMP‐2. Overall, our findings establish stromelysin‐1 as a crucial mediator of glucotoxic injury in islet microvascular endothelial cells.
- 20 March 2026
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 30 (6) , e71098
Open AccessConsequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells
The integrity of the pancreatic islet microvasculature is critical for endocrine function, yet it is progressively compromised by glucotoxicity in diabetes. While matrix metalloproteinases are implicated, the role of stromelysin‐1 as a potential upstream driver of endothelial dysfunction remains poorly defined. The aim of our study was to elucidate the role of stromelysin‐1 in mediating glucotoxic injury to islet microvascular endothelial cells (IMECs). To this end, we employed a CRISPR/Cas9‐mediated knockout of stromelysin‐1 in IMECs. Cellular functions, including proliferation, migration, and angiogenesis, were assessed using IncuCyte ZOOM live‐cell imaging, while endothelial barrier integrity was quantified via a 40 kDa dextran flux assay. Additionally, the secretome was profiled using a cytokine antibody array. We found that genetic ablation of stromelysin‐1 conferred protection against glucotoxicity. Stromelysin‐1 KO IMECs exhibited significantly enhanced proliferation, migration, and angiogenic capacity compared to wild‐type controls. Furthermore, stromelysin‐1 deficiency restored endothelial monolayer integrity by attenuating high‐glucose‐induced hyperpermeability. These functional improvements were linked to a remodelling of the secretome, characterised by decreased secretion of the pro‐degradative MMP‐2 and increased secretion of the anti‐inflammatory cytokine IL‐10 and the endogenous inhibitor TIMP‐2. Overall, our findings establish stromelysin‐1 as a crucial mediator of glucotoxic injury in islet microvascular endothelial cells.
- Open Access
- 26 February 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (5) , 4066-4081
Rapid improvement of renal microcirculatory homeostasis by liraglutide following diabetes induction
Aims: Renal microvascular dysfunction is a central driver of diabetic kidney disease, yet the potential for rapid therapeutic reversal remains obscure. We investigated the effect of short‐term liraglutide on early changes in the renal microcirculation post‐induction of diabetes. Materials and Methods: Type 2 diabetes mellitus (T2DM) was induced in BALB/c mice via high‐fat diet and streptozotocin. Following induction, mice received insulin or liraglutide treatments for 1 or 2 weeks. Renal microhemodynamics was analysed using laser Doppler flowmetry and wavelet analysis. Histopathological evaluations via Masson trichrome and haematoxylin–eosin staining assessed fibrosis and microvascular integrity. Primary renal microvascular endothelial cells (RMECs) were isolated to evaluate angiogenic and migratory behaviours. Metabolomics analyses were performed to link metabolic changes with microcirculatory alterations. Results: T2DM induced significant impairments in renal microcirculation, characterised by dysregulated microhemodynamics, disturbed oxygen saturation, altered haemoglobin distribution and compromised blood perfusion. These functional defects were accompanied by elevated creatinine, reduced cystatin C and impaired angiogenic and migratory capacity of RMECs under glucotoxicity. Both insulin and liraglutide treatments ameliorated renal microcirculatory oxygen profiles and improved renal function biomarkers. Histological data revealed decreased fibrosis and enhanced microvascular architecture post‐treatment. Metabolomic profiling revealed that liraglutide preferentially restored depleted amino acid levels associated with microvascular function, a change associated with the normalisation of metabolic profiles potentially involving peptide transport pathways. Conclusions: Our findings demonstrate that short‐term liraglutide restores renal microcirculatory homeostasis in the post‐induction phase, mitigating microvascular dysfunction and preserving kidney structure, highlighting the potential therapeutic value in preventing the progression of diabetic renal injury.
- 26 February 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (5) , 4066-4081
Open AccessRapid improvement of renal microcirculatory homeostasis by liraglutide following diabetes induction
Aims: Renal microvascular dysfunction is a central driver of diabetic kidney disease, yet the potential for rapid therapeutic reversal remains obscure. We investigated the effect of short‐term liraglutide on early changes in the renal microcirculation post‐induction of diabetes. Materials and Methods: Type 2 diabetes mellitus (T2DM) was induced in BALB/c mice via high‐fat diet and streptozotocin. Following induction, mice received insulin or liraglutide treatments for 1 or 2 weeks. Renal microhemodynamics was analysed using laser Doppler flowmetry and wavelet analysis. Histopathological evaluations via Masson trichrome and haematoxylin–eosin staining assessed fibrosis and microvascular integrity. Primary renal microvascular endothelial cells (RMECs) were isolated to evaluate angiogenic and migratory behaviours. Metabolomics analyses were performed to link metabolic changes with microcirculatory alterations. Results: T2DM induced significant impairments in renal microcirculation, characterised by dysregulated microhemodynamics, disturbed oxygen saturation, altered haemoglobin distribution and compromised blood perfusion. These functional defects were accompanied by elevated creatinine, reduced cystatin C and impaired angiogenic and migratory capacity of RMECs under glucotoxicity. Both insulin and liraglutide treatments ameliorated renal microcirculatory oxygen profiles and improved renal function biomarkers. Histological data revealed decreased fibrosis and enhanced microvascular architecture post‐treatment. Metabolomic profiling revealed that liraglutide preferentially restored depleted amino acid levels associated with microvascular function, a change associated with the normalisation of metabolic profiles potentially involving peptide transport pathways. Conclusions: Our findings demonstrate that short‐term liraglutide restores renal microcirculatory homeostasis in the post‐induction phase, mitigating microvascular dysfunction and preserving kidney structure, highlighting the potential therapeutic value in preventing the progression of diabetic renal injury.
- Open Access
- 12 January 2026
- Published by Elsevier in Phytomedicine
- Vol. 151, 157828
Modulation of gut microbiota by the herbal formulation Intestinal Flora Balance rescues pancreatic and intestinal microvascular dysfunction to alleviate type 2 diabetes mellitus
- 12 January 2026
- Published by Elsevier in Phytomedicine
- Vol. 151, 157828
Open AccessModulation of gut microbiota by the herbal formulation Intestinal Flora Balance rescues pancreatic and intestinal microvascular dysfunction to alleviate type 2 diabetes mellitus